OptimizeRx Corp
OPRX· Nasdaq
OPRXOptimizeRx Corp
Filed Aug 14, 2012 · 10-Q · 45 days after period end · 0001255294-12-000605
| Metric | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|
| Revenue | $515.42K | $200.17K | $16.72K |
| Net Income | -$76.06K | -$432.68K | -$874.90K |
| EPS Diluted | -$0.01 | — | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
OptimizeRx Corp · CIK 1448431 · Engraved from SEC EDGAR
ended Jun 30, 2012 · filed Aug 14, 2012 · 45 d after period end
